PET-CT to Assess Brain Damage in Cardiac Arrest Patients

Launched by CAPITAL MEDICAL UNIVERSITY · Oct 24, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "PET-CT to Assess Brain Damage in Cardiac Arrest Patients," aims to understand how cardiac arrest affects the brain. After a patient successfully receives CPR and has stable heart function for at least 24 hours, they will undergo a special brain scan called a PET-CT. This scan helps doctors look at important aspects of brain health, like how well the brain is using oxygen and blood. The goal is to see how much brain damage may have occurred and to follow up with the patients six months later to assess their recovery.

To take part in this study, patients must be at least 18 years old, have been unconscious after their cardiac arrest, and have stable heart function for a specific time. However, those who have other serious brain injuries or are pregnant cannot participate. During the trial, participants will be monitored closely for their safety while the scans are being conducted. This study is important because it could help improve how we care for patients who have experienced cardiac arrest and understand their brain health better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age ≥18 years.
• • sustained hemodynamic stability for ≥24h.
• • the patients were unconscious and not able to obey verbal commands. • Advanced life support and target temperature management within 6 hours of return of spontaneous circulation (ROSC).
• Exclusion Criteria:
• • Patients with hemodynamic instability.
• • Patients who could not complete cranial PET-CT examination for special reasons. • Patients during pregnancy.
• • Patients who combined traumatic brain injury, stroke, cerebral hemorrhage and other diseases.
• • Patients whose family members did not agree to be enrolled.